GlassScriptPhysician profile
Hannah Marie Miller
NPI 1831750512
$8,685.86
in general payments reported to CMS, 2019-2025
23 companies · $2,883 in 2025
The $2,883 reported for 2025 was more than what 91% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.48 · 2020: $172 · 2021: $561 · 2022: $1,251 · 2023: $1,721 · 2024: $2,085 · 2025: $2,883.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,688.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $1,708.61 | 2020-2025 | Tecnis Iol, Tecnis Simplicity, Catalys System |
| New World Medical,INC. | $1,075.91 | 2021-2025 | Kahook Dual Blade, Streamline, Clearpath |
| Glaukos Corporation | $1,000.35 | 2021-2025 | Istent Trabecular Micro-Bypass System Model Is3, Idosetr, Idose |
| Alcon Vision LLC | $973.45 | 2023-2025 | Hydrus Microstent, Clareon, Rocklatan |
| Abbvie INC. | $829.87 | 2023-2025 | |
| Bausch & Lomb Americas INC. | $649.49 | 2022-2025 | Stellaris, Vyzulta, Miebo |
| Amgen INC. | $641.36 | 2024-2025 | Tepezza |
| Sight Sciences, INC. | $591.79 | 2021-2025 | Omni Surgical System, Sion Surgical Instrument |
| Tarsus Pharmaceuticals, INC. | $328.93 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $236.54 | 2024-2025 | |
| Nova Eye, INC. | $147.09 | 2025 | |
| Argenx US, INC. | $110.93 | 2025 | |
| Biotissue Holdings INC. | $98.32 | 2024-2025 | |
| Carl Zeiss Meditec Cataract Technology INC. | $81.09 | 2022 | |
| Carl Zeiss Meditec USA, INC. | $51.06 | 2023 | Quatera 700 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $24.49 | 2021 | |
| Thea Pharma INC. | $22.40 | 2023 | Iyuzeh |
| Rayner Intraocular Lenses Limited | $21.61 | 2025 | Omidria |
| Harrow Eye, LLC | $20.87 | 2025 | |
| Notal Vision, INC. | $19.85 | 2024 | Foresee Home |
| Oyster Point Pharma, INC. | $19.77 | 2024 | Tyrvaya |
| Dompe US, INC. | $19.60 | 2024 | Oxervate |
| Genentech USA, INC. | $12.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.